Literature DB >> 5921287

Phenol motor point block in the management of muscular hypertonia.

D Halpern, F E Meelhuysen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5921287

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


× No keyword cloud information.
  8 in total

Review 1.  Chemodenervation for treatment of limb spasticity following spinal cord injury: a systematic review.

Authors:  J Lui; M Sarai; P B Mills
Journal:  Spinal Cord       Date:  2015-01-13       Impact factor: 2.772

2.  Peripheral nerve block and motor point block with phenol in the management of spasticity.

Authors:  E P Copp; R Harris; J Keenan
Journal:  Proc R Soc Med       Date:  1970-09

3.  Managing disability from stroke.

Authors:  J C Clifford
Journal:  Can Fam Physician       Date:  1986-03       Impact factor: 3.275

4.  Rehabilitation after stroke.

Authors:  F J Kottke
Journal:  Can Fam Physician       Date:  1970-12       Impact factor: 3.275

Review 5.  Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.

Authors:  Geoffrey Sheean
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

6.  The use of intrathecal phenol for muscle spasms in multiple sclerosis. A description of two cases.

Authors:  R A Browne; D V Catton
Journal:  Can Anaesth Soc J       Date:  1975-03

7.  Phenol reduces hypertonia and enhances strength: a longitudinal case study.

Authors:  Patrick H McCrea; Janice J Eng; Rhonda Willms
Journal:  Neurorehabil Neural Repair       Date:  2004-06       Impact factor: 3.919

8.  Phenol block in the management of spastic cerebral palsy.

Authors:  S L Yadav; U Singh; G P Dureja; K K Singh; S Chaturvedi
Journal:  Indian J Pediatr       Date:  1994 May-Jun       Impact factor: 1.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.